Korean Gliptins Loom Amid Signs Of Shifts In India

A clutch of new dipeptidyl peptidase-4 (DPP-4) inhibitors including LG Life Sciences Ltd's gemigliptin and Dong-A ST Co. Ltd 's evogliptin have either just hit the Indian market or are on the horizon, amid what some industry watchers say are early signs of a volume shake-up in the highly competitive gliptins market.